FdaApplication
BLA 103770
Identifiers
- fda_app_no: BLA103770
Properties
| Property | Value |
|---|---|
| applicant_name | Swedish Orphan Biovitrum AB (publ) |
| application_type | BLA |
| approval_date | 1998-06-19 |
Products (4)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| SYNAGIS | PALIVIZUMAB | 50MG | For Injection |
| SYNAGIS | PALIVIZUMAB | 100MG | For Injection |
| SYNAGIS | — | 50MG/0.5ML | Injection |
| SYNAGIS | — | 100MG/1ML | Injection |
4 products